Human trial
PEA primary study · PMID 27227691
Patients with spinal-cord-injury neuropathic pain in a randomized controlled trial.
Reported findings. No positive effect established on the stated primary outcome.
Nonresponse. The trial did not establish improvement in its primary pain outcome.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. Findings vary by indication and preparation. Neither a positive study in another pain condition nor mechanistic rationale proves universal pain relief.
Preparation: Ultramicronized PEA, add-on treatment. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.